- ISIN
- US3163907724
- CUSIP
- 316390772
- Issuer
- Fidelity
- Inception Date
- Dec 16, 1985
- Category
- Health & Biotech Equities
- Min. Investment
- $0
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Mid-Cap
- Asset Class Style
- Growth
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
FBIOX Performance Chart
Fidelity Select Biotechnology Portfolio (FBIOX) is up 0.0% since the beginning of the year. FBIOX is currently trading at $24 per share. Investors who bought $1,000 worth of FBIOX shares 5 years ago would now be looking at an investment worth $1,324.
Loading charts...
Returns By Period
Fidelity Select Biotechnology Portfolio (FBIOX) has returned 0.03% so far this year and 42.15% over the past 12 months. Over the last ten years, FBIOX has returned 9.09% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
Fidelity Select Biotechnology Portfolio
- 1D
- -3.67%
- 1M
- -3.79%
- YTD
- 0.03%
- 6M
- -0.21%
- 1Y
- 42.15%
- 3Y*
- 15.71%
- 5Y*
- 5.77%
- 10Y*
- 9.09%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
FBIOX Monthly Returns History
Based on dividend-adjusted daily data since Dec 16, 1985, FBIOX's average daily return is +0.06%, while the average monthly return is +1.25%. At this rate, an investment would double in approximately 4.6 years.
Historically, 59% of months were positive and 41% were negative. The best month was Feb 2000 with a return of +37.8%, while the worst month was Oct 1987 at -30.8%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, FBIOX closed higher 53% of trading days. The best single day was Oct 13, 2008 with a return of +11.9%, while the worst single day was Oct 19, 1987 at -17.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.47% | 2.43% | -1.76% | 0.32% | 3.56% | -5.71% | 0.03% | ||||||
| 2025 | 3.12% | 0.72% | -5.04% | -0.86% | -4.89% | 3.43% | 7.62% | 5.13% | 8.74% | 7.36% | 8.24% | -0.82% | 36.38% |
| 2024 | 1.51% | 7.90% | 0.92% | -10.56% | 4.72% | 5.33% | 8.26% | 1.53% | -0.33% | -0.09% | -1.51% | -8.76% | 7.26% |
| 2023 | 3.19% | -5.00% | -2.07% | 4.41% | 1.41% | 0.30% | 2.17% | -3.30% | -4.88% | -6.60% | 5.22% | 16.92% | 10.09% |
| 2022 | -16.12% | -2.77% | 2.53% | -13.72% | -3.94% | 8.05% | 4.35% | 4.70% | -2.15% | 3.49% | 3.12% | -1.51% | -15.87% |
| 2021 | 0.64% | 0.63% | -5.57% | 0.30% | -5.09% | 6.40% | -2.03% | 5.91% | -5.11% | -1.30% | -6.05% | -0.78% | -12.26% |
Benchmark Metrics
Fidelity Select Biotechnology Portfolio has an annualized alpha of 5.31%, beta of 0.95, and R2 of 0.44 versus S&P 500 Index. Calculated based on daily prices since December 17, 1985.
- This fund captured 105.29% of S&P 500 Index gains but only 91.03% of its losses - a favorable profile for investors.
- R2 of 0.44 means the benchmark explains less than half of this fund's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 5.31%
- Beta
- 0.95
- R²
- 0.44
- Upside Capture
- 105.29%
- Downside Capture
- 91.03%
Expense Ratio
FBIOX has an expense ratio of 0.69%, placing it in the medium range.
Return for Risk
Risk / Return Rank
FBIOX ranks 66 for risk / return — better than 66% of mutual funds on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and compare them to S&P 500 Index.
| FBIOX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.12 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.41 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 5.81 | 2.93 | +2.88 |
| Martin ratioReturn relative to average drawdown | 18.24 | 13.52 | +4.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Fidelity Select Biotechnology Portfolio provided a 6.72% dividend yield over the last twelve months, with an annual payout of $1.62 per share. The fund has been increasing its distributions for 2 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.62 | $0.62 | $0.23 | $0.08 | $0.00 | $2.80 | $4.90 | $1.96 | $1.98 | $0.31 | $0.60 | $1.58 |
Dividend yield | 6.72% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Select Biotechnology Portfolio. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $1.06 | $0.00 | $0.00 | $1.06 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.56 | $0.62 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.23 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.08 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $1.70 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.10 | $2.80 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Select Biotechnology Portfolio. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Select Biotechnology Portfolio was 71.98%, occurring on Jul 10, 2002. Recovery took 2514 trading sessions.
The current Fidelity Select Biotechnology Portfolio drawdown is 7.02%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Dot-com crash2000–2002 | -71.98%Jul 2002 | 2y 4mo | 9y 12mo | 12y 4moMar 2000 - Jul 2012 |
Bear market2022 | -48.66%May 2022 | 1y 2mo | 3y 5mo | 4y 8moFeb 2021 - Oct 2025 |
2016 bear market2016 | -46.02%Feb 2016 | 6mo 26d | 3y 10mo | 4y 5moJul 2015 - Dec 2019 |
Black Monday1987 | -43.64%Oct 1987 | 7mo 5d | 1y 11mo | 2y 6moMar 1987 - Oct 1989 |
1993 bear market1993 | -36.56%Apr 1993 | 1y 2mo | 2y 8mo | 3y 11moJan 1992 - Dec 1995 |
Drawdown Indicators
| FBIOX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.98% | -56.78% | -15.20% |
Max Drawdown (1Y)Largest decline over 1 year | -7.62% | -9.10% | +1.48% |
Max Drawdown (3Y)Largest decline over 3 years | -27.83% | -18.90% | -8.93% |
Max Drawdown (5Y)Largest decline over 5 years | -44.87% | -25.43% | -19.44% |
Max Drawdown (10Y)Largest decline over 10 years | -48.66% | -33.92% | -14.74% |
Current DrawdownCurrent decline from peak | -7.02% | -0.74% | -6.28% |
Average DrawdownAverage peak-to-trough decline | -23.63% | -10.72% | -12.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.42% | 1.97% | +0.45% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with FBIOX
Add Fidelity Select Biotechnology Portfolio to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with FBIOX